IRWIN NATURALS 4 HEALTH
8-K/A, 1999-06-07
FABRICATED PLATE WORK (BOILER SHOPS)
Previous: NUVEEN CALIFORNIA PERFORMANCE PLUS MUNICIPAL FUND INC, N-2/A, 1999-06-07
Next: IRWIN NATURALS 4 HEALTH, 8-K/A, 1999-06-07



<PAGE>

                       SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON, DC 20549

                                   FORM 8-K/A

                                 CURRENT REPORT



                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934


                Date of Report (Date of earliest event reported)
                        JUNE 7, 1999 (FEBRUARY 17, 1999)



                          IRWIN NATURALS/4HEALTH, INC.
             (Exact name of registrant as specified in its charter)


            UTAH                   0-18160                 87-046822
(State of other jurisdiction    (Commission             (IRS Employer
     of incorporation)          File Number)         Identification No.)



                           10549 WEST JEFFERSON BLVD.,
                              CULVER CITY, CA 90232
                    (Address of Principal Executive Offices)

       Registrant's telephone number, including area code: (310) 253-5305


                                       N/A
         (Former name and former address, if changed since last report)



<PAGE>

         ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS.

         This Form 8-K/A amends the Form 8-K filed with the Securities and
Exchange Commission on March 4, 1999 (the "Prior Form 8-K"), by Irwin
Naturals/4Health, Inc., a Utah corporation ("IN"), in connection with the
merger of Health & Vitamin Express, Inc., a California corporation, with and
into HealthZone.com, a California corporation wholly-owned by IN.

         This Form 8-K/A amends the Prior Form 8-K by setting forth the
following financial information required to be reported by Item 7 of Form 8-K.

                  (a)      Financial Statements of Businesses Acquired.

                           Balance Sheet of Health & Vitamin Express, Inc. as at
                           December 31, 1998 and the related statements of
                           income and retained earnings and cash flows for the
                           year then ended together with the notes thereto, as
                           audited by Samuel H. Wong & Co., LLP, independent
                           accountants, as stated in their report therein.

                  (b)      Pro Forma Financial Information.

                           Pro Forma statement balance sheet as of December 31,
                           1998 and Pro Forma statement of operations for the
                           year ended December 31, 1998 and explanatory notes.

                  (c)      Exhibits

                           Exhibit 10.10    April 16, 1999 letter of intent
                                            with Klee Irwin

                           Exhibit 10.11    April 19, 1999 indemnity agreement
                                            with Klee Irwin



                                       1

<PAGE>

THIS REPORT ON FORM 8-K/A INCLUDES "FORWARD-LOOKING STATEMENTS" WITHIN THE
MEANING OF SECTION 27A OF THE SECURITIES ACT OF 1933, AS AMENDED (THE
"SECURITIES ACT") AND SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934, AS
AMENDED (THE "EXCHANGE ACT"). ALL STATEMENTS OTHER THAN STATEMENTS OF
HISTORICAL FACTS INCLUDED IN THIS REPORT, INCLUDING, WITHOUT LIMITATION,
THOSE REGARDING THE COMPANY'S FINANCIAL POSITION, BUSINESS, MARKETING AND
PRODUCT INTRODUCTION AND DEVELOPMENT PLANS AND OBJECTIVES OF MANAGEMENT FOR
FUTURE OPERATIONS, ARE FORWARD-LOOKING STATEMENTS. ALTHOUGH THE COMPANY
BELIEVES THAT THE EXPECTATIONS REFLECTED IN SUCH FORWARD-LOOKING STATEMENTS
ARE REASONABLE, IT CAN GIVE NO ASSURANCE THAT SUCH EXPECTATIONS WILL PROVE TO
HAVE BEEN CORRECT. IMPORTANT FACTORS THAT COULD CAUSE ACTUAL RESULTS TO
DIFFER MATERIALLY FROM THE COMPANY'S EXPECTATIONS ("CAUTIONARY STATEMENTS")
ARE DISCLOSED UNDER "RISKS RELATED TO THE BUSINESS OF 4HEALTH" AND ELSEWHERE
IN THE COMPANY'S ANNUAL REPORT ON FORM 10-K AND IN "MANAGEMENT'S DISCUSSION
AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS" AND ELSEWHERE
IN THE ANNUAL REPORT. ALL SUBSEQUENT WRITTEN AND ORAL FORWARD-LOOKING
STATEMENTS ATTRIBUTABLE TO THE COMPANY OR PERSONS ACTING ON BEHALF OF THE
COMPANY, ARE EXPRESSLY QUALIFIED IN THEIR ENTIRETY BY THE CAUTIONARY
STATEMENTS.

             ITEM 7 (a) - Financial Statements of Business to be Acquired

To the Board of Directors
Irwin Naturals/4Health, Inc.

We have audited the accompanying balance sheet of Health & Vitamin Express,
Inc. as of December 31, 1998, and the related statements of income, retained
earnings, and cash flows for the year then ended. These financial statements
are the responsibility of the Company's management. Our responsibility is to
express an opinion on these financial statements based on our audit.

Except as discussed in the following paragraph, we conducted our audit in
accordance with generally accepted auditing standards. Those standards
require that we plan and perform the audit to obtain reasonable assurance
about whether the financial statements are free of material misstatement. An
audit includes examining, on a test basis, evidence supporting the amounts
and disclosures in the financial statements. An audit also includes assessing
the accounting principles used and significant estimates made by management,
as well as evaluating the overall financial statement presentation. We
believe that our audit provides a reasonable basis for our opinion.

We did not observe the taking of the physical inventories at December 31,
1998, (stated at $33,061) since that date was prior to the time we were
engaged as auditors for the Company. We were unable to satisfy ourselves
about inventory quantities by means of other auditing procedures.

In our opinion, except for the effects of such adjustments, if any, as might
have been determined to be necessary had we been able to observe the physical
inventories taken of December 31, 1998, the financial statements referred to
the first paragraph present fairly, in all material respects, the financial
position of Health & Vitamin Express, Inc. as of December 31, 1998, and the
results of its operations and its cash flows for the year then ended in
conformity with generally accepted accounting principles.

The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. As discussed in Note 10 to the
financial statements, the Company's significant operating losses raise
substantial doubt about its ability to continue as a going concern. The
financial statements do not include any adjustments that might result from
the outcome of this uncertainty.


                                      2

<PAGE>

May 6, 1999                                           Samuel H. Wong & Co., LLP
San Francisco, California                          Certified Public Accountants



                                      3

<PAGE>

                         Health & Vitamin Express, Inc.
                                  Balance Sheet
                                December 31, 1998
<TABLE>
<CAPTION>
Assets
                                                                                                         1998
<S>                                                                                               <C>
Current Assets

     Accounts Receivable                                                                                1,259
     Inventory                                                                                         33,061
     Prepaid Expenses                                                                                   4,237
                                                                                                    ---------
                                                                           Total Current Assets        38,557

Property and Equipment                        (Notes 3)
     At Cost                                                                                           55,125
     Accumulated Depreciation                                                                         (42,029)
                                                                                                    ---------
                                                                                                       13,096

Other Assets                                  (Note 4)
     Security Deposits                                                                                  4,711
                                                                                                    ---------
                                                                                Total Assets        $  56,364
                                                                                                    ---------
                                                                                                    ---------

<CAPTION>
Liabilities and Stockholders' Equity
                                                                                                         1998
<S>                                                                                               <C>
Current Liabilities
     Accounts Payable                                                                               $  66,116
     Payroll Taxes Liabilities                                                                          2,975
     Taxes Payable                                                                                      2,688
     Accrued Expenses                                                                                  57,030
     Accrued Interest Payable                                                                          11,516
     Notes Payable                            (Note 7)                                                443,785
                                                                                                    ---------
                                                                    Total Current Liabilities         584,110

Stockholders' Equity
     Common Stock Capital                     (Note 8)                                                 35,450
     Retained Deficits                                                                               (563,196)
                                                                                                    ---------
                                                                                                     (527,746)
                                                                                                    ---------
                                                  Total Liabilities and Stockholders' Equity        $  56,364
                                                                                                    ---------
                                                                                                    ---------
</TABLE>

                  See Accompanying Notes and Accountants' Report


                                         4


<PAGE>

                         Health & Vitamin Express, Inc.
                   Statements of Income and Retained Earnings
                          Year Ended December 31, 1998

<TABLE>
<CAPTION>
                                                                                                     1998
<S>                                                                                                <C>
Net Sales                                                                                          $ 662,180

Cost of Good Sold                                                                                   (359,045)
                                                                                                     -------
                                                                                 Gross Profit        303,135

Selling, General, and Administrative Expenses
     Administrative Expenses                                                                         260,215
     Advertising & Marketing Expenses                                                                269,566
     Salaries and Wages                                                                               93,034
     Employee Benefits                                                                                28,985
     Financial Expenses                                                                               31,559
     Depreciation & Amortization                                                                       3,191
                                                                                                     -------
                                                                                                     686,550
                                                                                                     -------
                                                                       (Loss) From Operations       (383,415)

Other Income/(Expense)
     Net Other Income                                                                                 11,694
                                                                                                     -------
                                                                    (Loss) Before Income Taxes      (371,721)

Income Taxes
     Current                     (Note 5)                                                               (---)
                                                                                                     -------

                                                                                    Net (Loss)      (371,721)
Beginning Retained Deficit                                                                          (191,475)
                                                                                                     -------

Ending Retained Deficits                                                                           $(563,196)
                                                                                                     -------
                                                                                                     -------
</TABLE>

                  See Accompanying Notes and Accountants' Report


                                         5


<PAGE>

                         Health & Vitamin Express, Inc.
                             Statement of Cash Flows
                          Year Ended December 31, 1998
<TABLE>
<CAPTION>
                                                                                                        1998
<S>                                                                                              <C>
Cash Flows From Operating Activities
     Net Loss                                                                                      $(371,721)
     Adjustments to reconcile net income to
     net cash provided by operating activities
         Depreciation and Amortization                                                                 3,191
     (Increase)/Decrease in:
         Accounts Receivable                                                                             850
         Inventory                                                                                   (31,838)
         Prepaid Expenses                                                                             16,596
     Increase/(Decrease) in:
         Accounts Payable                                                                            (44,697)
         Accrued Interest Payable                                                                     11,517
         Other Current Liabilities                                                                    34,604
                                                                                                   ---------
                                                      Net Cash (Used)  by Operating Activities      (381,498)

Cash Flows From Investing Activities
     Purchase of Property and Equipment                                                              (10,319)
                                                                                                   ---------
                                                       Net Cash (Used) by Investing Activities       (10,319)

Cash Flows From Financing Activities
     Net Proceeds/(Repayments) of Loan from Shareholder                                              124,768
     Net Proceeds of Loan from Warrant Holder                                                        250,000
     Net Additions to Security Deposits                                                               (3,160)
     Issuance of Common Stock                                                                            250
                                                                                                   ---------
                                            Net Cash (Used)/Provided  by Financing Activities        371,858
                                                                                                   ---------
                                                                       Net (Decreased) in Cash       (19,959)

Cash at Beginning of Year                                                                             19,959
                                                                                                   ---------
                                                                         Cash at End of Year $           ---
                                                                                                   ---------
                                                                                                   ---------

Supplemental Disclosures
     Interest Paid                                                                                   (17,272)
</TABLE>
                  See Accompanying Notes and Accountants' Report


                                         6

<PAGE>

                         Health & Vitamin Express, Inc.
                          Notes to Financial Statements
                          Year Ended December 31, 1998


1.       The Company

         Health & Vitamin Express, Inc. (formerly: Vitamin Nutrition Center,
         Inc.) is a California Corporation incorporated on September 28, 1992
         and began operations shortly after inception. The Company is an on-line
         specialty retailer of nutritional supplements and other health and
         self-care products.


2.       Summary of Significant Accounting Policies

         (a)      Basis of Reporting

                  The Company maintains its general ledger and journals with the
                  accrual method of accounting, for financial reporting and
                  income tax reporting purposes. Accordingly, the accompanying
                  financial statements are prepared on the accrual basis of
                  accounting. In preparing financial statements in conformity
                  with generally accepted accounting principles, management is
                  required to make estimates and assumptions that affect the
                  reported amounts of assets and liabilities at the date of the
                  financial statements and revenue and expenses during the
                  reporting period. Actual results could differ from those
                  estimates.

         (b)      Inventories

                  Inventories are stated at the lower of cost or market value.

         (c)      Property and Equipment

                  Property and Equipment are stated at cost. Repairs and
                  maintenance of these assets are charged to expense as
                  incurred; major improvements enhancing the function and/or
                  useful life of these assets are capitalized. When an asset is
                  sold or retired, its cost and related accumulated depreciation
                  are removed from the accounts and any gain/loss arising from
                  such transaction is recognized.

                  Property and Equipment are depreciated by the straight line
                  method over their estimated useful lives of 5 years.

         (d)      Organization Cost

                  Organization Cost has been fully amortized over a period of 60
                  months.


                                       7

<PAGE>

         (e)      Income Taxes

                  The Company uses the accrual method of accounting to determine
                  and report its taxable income and the flow-through method to
                  account for tax credits, which are reflected as a reduction of
                  income taxes for the year in which they are available.

                  In February 1992, the Financial Accounting Standards Board
                  issued Statement of Financial Accounting Standards (SFAS) No.
                  109, Accounting for Income Taxes. The Company has implemented
                  this standard.

                  Income tax liabilities computed according to the Federal and
                  California tax laws, are provided for the tax effects of
                  transactions reported in the financial statements and consist
                  of taxes currently due plus deferred taxes related primarily
                  to differences between the basis of fixed assets and
                  intangible assets for financial and tax reporting. The
                  deferred tax assets and liabilities represent the future tax
                  return consequences of those differences, which will either be
                  taxable or deductible when the assets and liabilities are
                  recovered or settled. Deferred taxes also are recognized for
                  operating losses and passive activity losses that are
                  available to offset future taxable income and tax credits that
                  are available to offset future Federal and California income
                  taxes.

         (f)      Cash Flows

                  For the statements of cash flows, the company considers all
                  highly liquid debt instruments with maturity dates of three
                  months or less to be cash equivalents.


3.       Property and Equipment

         Property and Equipment are stated at cost, less accumulated
         depreciation, and are summarized as follows at December 31:-
<TABLE>
<CAPTION>
                                                                                     1998
                  <S>                                                      <C>
                  Machinery & Equipment                                    $        52,618
                  Furniture & Fixtures                                               2,507
                                                                                ----------
                                                                                    55,125
                  Less: Accumulated Depreciation                                   (42,029)
                                                                                ----------
                                                                           $        13,096
                                                                                ----------
                                                                                ----------
</TABLE>

 4.      Other Assets

         Other Assets of $4,711 at December 31, 1998 were consisted of Security
         Deposits.


                                       8

<PAGE>

5.       Income Taxes

         The Company incurred minimum $800 state income tax expense for the year
         ended December 31, 1998. Deferred income taxes reflect the estimated
         future tax effect of temporary differences between amounts for
         financial reporting purposes and as measured by tax laws and
         regulations for assets and liabilities. Deferred tax, after a valuation
         allowance is zero as of December 31, 1998.
<TABLE>
<CAPTION>
         1998
         Components                                 Federal           California            Total
         <S>                                      <C>                 <C>                 <C>
         Temporary Differences in
           Depreciation and Amortization          $    (148)          $     (52)          $    (200)
         Net Operating Losses
           Carryforward                             116,068              40,744             156,812
                                                  ---------           ---------           ---------
                                                  $ 115,920           $  40,692           $ 156,612
         Less:  Valuation Allowance                (115,920)            (40,692)           (156,612)
                                                  ---------           ---------           ---------
                                                  $     ---           $     ---           $     ---
</TABLE>

         A valuation allowance has been established due to the uncertainty
         associated with the realizability of the deferred tax assets.


6.       Lease Commitments

         The Company entered into a lease of an office space at 5751 Uplander
         Way, Culver City, CA 90230, which expired on December 31, 1998, was
         extended to December 31, 1999 at a rent of $1,474 per month. The
         Company also entered into a lease with a Shareholder's father, certain
         premises at 10852 Wilkins Avenue, Los Angeles, CA 90024 for a term
         co-terminus with the office lease at a fixed rent of $1,400 per month.
         The minimum lease payments for the year 1999 are at a total of $34,488.


                                       9


<PAGE>

7.        Notes Payable

         At December 31, 1998, notes payable are comprised of the following:
<TABLE>
<CAPTION>
                                                                                                               1998
         <C>      <S>                                                                                      <C>
         a)       Note payable to a shareholder, secured by Company's  assets
                  interest-bearing at 10%, due on December 31, 1998                                        $143,785

         b)       Unsecured notes payable to a shareholder, interest-bearing at 10%,
                  principal and interest are due on demand                                                   50,000

         c)       Unsecured note payable to a share warrant holder,
                  interest-bearing at 10%, payable monthly,
                  due on September 30, 1999                                                                 250,000
                                                                                                           --------

                                                                                                           $443,785
                                                                                                           --------
                                                                                                           --------
</TABLE>

 8.      Common Stock

         The Company is authorized by its Restated Articles of Incorporation
         (filed with the Secretary of State on July 25, 1997) to issue a total
         of 100,000,000 shares of common stock and 10,000,000 shares of
         preferred stock at no par value per share, of which 10,250,000 shares
         of common stock were issued and outstanding at December 31, 1998, after
         a stock split of 1 share to 750 shares on July 25, 1997.


 9.      Business Acquisition

         On March 1, 1998, the Company acquired certain assets including
         goodwill from Prozyme of California for $25,973.65.


 10.     Going Concern

         As shown in the accompanying financial statements, the Company incurred
         a net loss of $371,721 during the year ended December 31, 1998, and as
         of that date, the Company's current liabilities exceeded its current
         assets by $545,553 and its total liabilities exceeded its total assets
         by $527,746, representing stockholders' deficits. These factors
         together with the Company's loan of $143,785 from a shareholder which
         is due on December 31, 1998, create an uncertainty about the Company's
         ability to continue as a going concern. The financial statements do not
         include any adjustments that might be necessary if the Company is
         unable to continue as a going concern.


                                       10

<PAGE>


11.      Year 2000 Issue

         Management of Health & Vitamin Express Inc. is aware of the Year 2000
         technical issues and have made its software systems (basically the Mail
         Order Management and Quickbooks Accounting 6.0 Version) and computer
         hardware systems Year 2000 compliant. No further expenditure is
         required to upgrade/replace its computer equipment.



                                        11


<PAGE>

                   ITEM 7 (b), Pro Forma Financial Information

On February 15, 1999, the Company acquired for $2,880,000, Health & Vitamin
Express, Inc. (HVE) by way of merger with and into the Company's newly formed
wholly-owned subsidiary HeathZone.com. The purchase consideration consisted
of the issuance of 363,636 shares of the Company's common stock valued at
$2,273,000 ($6.25 per share) and the assumption of $571,000 of debt. The
Company has accounted for the acquisition as a purchase, and the excess of
the purchase price of $2,880,000 over the fair value of net assets acquired
has been allocated to goodwill and is being amortized over 15 years.

In addition to the 363,636 shares issued upon acquisition, the Company is
contingently obligated to issue to the former shareholders of HVE (i) up to
272,727 shares of the Company's common stock based upon certain revenue
thresholds to be met by HVE during first 42 months subsequent to February 15,
1999 (the "Revenue" shares), and (ii) up to 90,909 shares of the Company's
common stock based upon certain profit thresholds to be met by HVE during the
first seven years subsequent to February 15, 1999 (the "Profit" shares). The
Company has the right to repurchase up to 65% of the shares issued for a
period of one (1) year following the date of issuance at a purchase price of
$13.75 per share (the "Repurchase Price"). The Repurchase Price may be
adjusted if upon repurchase the closing bid price of the Company's common
stock as quoted on the Nasdaq National Market System exceeds $20 per share
(the "Market Price"), the Company will pay to the sellers 50% of the
difference between the Market Price and $20 per share. Furthermore, in the
event Revenue and Profit shares are issued because of a funding failure, the
Repurchase Price shall be reduced to $9.63 per share. The Company has granted
to the Sellers certain "demand registration rights" and "piggyback
registration rights" on these shares, if issued, in the event the Company
undertakes a sale of its securities to the public..

In addition, the Company is obligated to invest or contribute to HVE
operations a minimum of (A) $4,000,000 during the 18 months subsequent to
February 15, 1999 and (B) $10,000,000 (inclusive of the $4,000,000 provided
in clause (A) above) during the 36 months subsequent to February 15, 1999. If
the Company fails to make the investments or contributions defined above, the
former shareholders of HVE will automatically receive the maximum allowable
shares subject to issuance under the provisions relating to the Revenue and
Profit Shares. The Company is currently prohibited by its existing credit
facility of making such investments or contributions.

On April 19, 1999 the Company and Klee Irwin, the Company's former Chief
Executive Officer, entered into an agreement whereby Mr. Irwin agreed to; i)
assume all of the Company's obligations to issue the Revenue and Profit
shares, and ii) reimburse and indemnify the Company for any losses, costs and
expenses incurred by HVE and in connection with the establishment of the
Healthzone.com subsidiary, from 1,600,000 shares of Company common stock he
currently owns.

The following unaudited pro forma condensed income statement gives effect to
the acquisition as if it had occurred at the beginning of the period, while
the unaudited pro forma condensed balance sheet gives effect to the
acquisition as if it had occurred as at December 31, 1998. Pro forma
adjustments include only the effects of events directly attributable to the
transaction that are expected to have a continuing impact and that are
factually supportable. The notes to the pro forma financial information
describe the pro forma amounts and adjustments described below. The pro forma
financial information does not necessarily reflect the operating results that
would have occurred had the acquisition been consummated as of the above
dates, nor is such information indicative of future operating results. See
the discussion relating to the "Forward Looking" information above. The
information shown below should be read in conjunction with the historical
financial statements of HVE and IN, including the respective notes thereto.


                                      12

<PAGE>

            IRWIN NATURALS/4HEALTH, INC
            UNAUDITED PRO FORMA CONDENSED BALANCE SHEET
            DECEMBER 31, 1998
<TABLE>
<CAPTION>
                                          Company         Health & Vitamin   Pro Forma            Combined
                                          -------         ----------------                        ---------
                                                               Express       Adjustments
                                                               -------       -----------
<S>                                      <C>                    <C>          <C>                   <C>
ASSETS
Cash                                      $426,000                                                  $426,000
Accounts receivable, net                 6,023,000              $1,000                             6,024,000
Inventories                              2,855,000              33,000                             2,888,000
Building held for sale                   1,521,000                                                 1,521,000
Property and equipment, net                627,000              13,000                               640,000
Goodwill of HVE                                                               2,837,000 (3)        2,837,000
Other assets                             1,635,000               9,000                             1,644,000
                                    -------------------------------------------------------------------------
Total assets                           $13,087,000             $56,000       $2,837,000          $15,980,000
                                    -------------------------------------------------------------------------
                                    -------------------------------------------------------------------------


LIABILITIES AND EQUITY
Accounts payable                        $2,637,000             $66,000          $36,000 (1)       $2,739,000
Accrued expenses                           942,000              74,000                             1,016,000
Notes payable                            1,751,000             444,000                             2,195,000
Line of credit                           1,000,000                                                 1,000,000
Other liabilities                          888,000                                                   888,000
                                    -------------------------------------------------------------------------
Total liabilities                        7,218,000             584,000           36,000            7,838,000

EQUITY
Common stock                               279,000              35,000         (35,000) (2)          283,000
                                                                                  4,000 (1)
Paid in capital                         14,333,000                            2,269,000 (1)       16,602,000
Treasury stock                            (50,000)                                                  (50,000)
Accumulated deficit                    (8,693,000)           (563,000)          563,000 (2)      (8,693,000)
                                    -------------------------------------------------------------------------
Total equity                             5,869,000           (528,000)        2,801,000            8,142,000

Total liabilities and equity           $13,087,000             $56,000       $2,837,000          $15,980,000
                                    -------------------------------------------------------------------------
                                    -------------------------------------------------------------------------
</TABLE>

Pro Forma Adjustments for the Unaudited Pro Forma Condensed Balance Sheet at
December 31, 1998 are as follows:

(1)  To reflect the acquisition costs of Health & Vitamin Express consisting of
     (i) issuance of 363,636 shares of common stock with a value of $6.25 per
     share and (ii) acquisition costs of $36,000.

(2)  To eliminate the acquired common stock and deficit of Health & Vitamin
     Express upon acquisition.

(3)  To reflect the allocation of the purchase price to goodwill, which will be
     amortized over 15 years.


                                       13


<PAGE>

                 IRWIN NATURALS/4HEALTH, INC
                 UNAUDITED PRO FORMA CONDENSED INCOME STATEMENT
                 DECEMBER 31, 1998
<TABLE>
<CAPTION>
                                               Company             Health & Vitamin   Pro Forma    Combined
                                               -------             ----------------                ---------
                                                                       Express       Adjustments
                                                                       -------       -----------
<S>                                           <C>                     <C>            <C>          <C>
Net sales                                     $30,547,000              $662,000                   $31,209,000

Cost of sales                                  12,945,000               359,000                    13,304,000
                                    -------------------------------------------------------------------------
Gross Profit                                   17,602,000               303,000                    17,905,000

Operating Expenses                             15,775,000               687,000       $192,000     16,654,000 (1)
                                    -------------------------------------------------------------------------
Income (loss) from operations                   1,827,000             (384,000)      (192,000)      1,251,000

Other income (expense)                          (209,000)                12,000                     (197,000)
                                    -------------------------------------------------------------------------
Income (loss) before taxes                      1,618,000             (372,000)      (192,000)      1,054,000

Provision for taxes                               600,000                              138,000        462,000 (3)
                                    -------------------------------------------------------------------------
Net income (loss)                              $1,018,000            ($372,000)      ($54,000)       $454,000
                                    -------------------------------------------------------------------------
                                    -------------------------------------------------------------------------

Earnings (loss) per common share
              Basic                                 $0.04                                               $0.02
              Diluted                                0.04                                                0.02

Weighted average common shares
              Outstanding - basic              27,747,000                              364,000     28,111,000 (2)

Weighted average common shares
              Outstanding - diluted            28,221,000                              364,000     28,585,000

</TABLE>

Pro Forma Adjustments for the Unaudited Pro Forma Condensed Income Statement at
December 31, 1998 are as follows:

(1)  To amortize the goodwill assigned to the acquisition for one year of the
     fifteen-year life.

(2)  To reflect issuance of shares of the Company's common stock upon
     acquisition

(3)  To adjust combined provision for taxes for effect of Health & Vitamin
     Express loss.


                                        14

<PAGE>


SIGNATURE


               Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.


                                     IRWIN NATURALS/4HEALTH, INC.


Date: June 7, 1999                            By:/s/ Lindsey Duncan
                                              ---------------------
                                              Lindsey Duncan
                                              Chairman of the Board





                                          15


<PAGE>

                    I R W I N  N A T U R A L S / 4 H E A L T H
                    MANUFACTURERS OF FINE NUTRITIONAL PRODUCTS

10549 W. Jefferson Blvd.
Culver City, California 90232
310.253.5305 Fax. 310.202.9454
- -------------------------------------------------------------------------------
- -------------------------------------------------------------------------------


                                                            April 16, 1999


Mr. Klee Irwin
7825 Veragua Drive
Playa del Rey, CA 90292


Dear Mr. Irwin:


     This will confirm our mutual intentions regarding the future status
of our wholly owned subsidiary HealthZone.com, a California corporation
("HealthZone.com") and your continued status as the Chief Executive Officer
of Irwin Naturals/4Health, Inc. (the "Company").

     1.   Subject to compliance with all applicable laws and assuming no
adverse tax consequences to the Company, as soon as practicable, the Company
will distribute to its stockholders as a stock dividend, 100% of the issued
and outstanding shares of voting capital stock of HealthZone (the
"Spin-Off"). Prior to the the Spin-Off, HealthZone will issue to the Company
a promissory note ("Note"), equaling the expenses (above gross profits)
invested in the setup, maintenance and acquisition of HVE and HealthZone.com,
including all costs that the Company has incurred and is currently incurring
and will incur in the future. As sole security and recourse collateral for
this liability, you will make a pledge of 363,636 shares of unencumbered
common stock of the Company ("Common Stock") registered in your and your
wife's joint names to cover the shares given to HVE, plus 314,464 additional
shares to cover up to $1 million in additional cash outlays by the company
related to HVE and HealthZone.com. This second figure is based on $1.5
million divided by $4.77. Shares required to be sold to fulfill this
obligation shall not be required to be converted under the price of $3.50 and
shall not be converted over the price of $6.00.

     2.   You will agree to assume all of the Company's obligations to issue
additional shares of Common Stock under that certain Agreement and Plan of
Merger ("Merger Agreement") dated February 15, 1999 by and among the Company,
Health & Vitamin Express, Inc. David Mandel, Jeffrey S. Segal and Gordon
Barker and the Employment Agreement with David Mandel from your own and your
wife's unencumbered shares of Common Stock, including, without limitation,
the issuance of additional Merger Consideration as provided in Section 2.02
of the Merger Agreement.

     3.   You shall resign as chief executive of the Company without Good
Reason and become chief executive officer of HealthZone.com. The Company
shall pay your salary at the same rate as your current salary until the
earlier of (A) the first anniversary


<PAGE>

of your appointment or (B) the first to occur of either (i) an initial public
offering or (ii) a merger, consolidation or reorganization of HealthZone or
the sale of all or substantially all of its assets.

     4.   You and the Company will negotiate, execute and deliver as soon as
practicable a definitive agreement, which will address all outstanding
matters involved in connection with the termination of your Employment
Agreement.

     The foregoing merely represents our mutual intentions with respect to
the subject matter hereof and shall not be deemed legally binding, unless and
until they are incorporated in one or more definitive agreements approved by
the Board of Directors of the Company, the provisions of which shall
supercede the provisions hereof.

     Notwithstanding the foregoing, pending the preparation, execution and
delivery of such definitive agreements, the following shall represent binding
agreements on your part:

     1.   You agree to keep the matters herein confidential and shall not
disclose them except with the written approval of the Chairman of the Board
of Directors, unless required by law.

     2.   You shall be responsible for your own fees and expenses, including,
without limitation, legal fees and disbursements incurred in connection with
the matters set forth herein.

     If the foregoing accurately sets forth our understanding reached to date
with respect to the subject matter hereof, please signify your approval and
acceptance by signing and returning the enclosed counterpart copy of this
letter to the undersigned.


                                                IRWIN NATURALS/4HEALTH, INC.



                                                By:   /s/ R. Lindsey Duncan
                                                   ---------------------------
                                                      R. Lindsey Duncan
                                                      Chairman

     APPROVED, ACCEPTED AND
     AGREED as of the date first above
     written



            /s/ Klee Irwin
     ---------------------------------
              Klee Irwin




IRWIN NATURALS/4HEALTH


Klee Irwin


<PAGE>

                                  KLEE IRWIN
                              7825 BERAGUA DRIVE
                            PLAYA DEL REY, CA 90292


The Board of Directors                                     April 19, 1999
Irwin Naturals/4Health, Inc.
10549 W. Jefferson Blvd.
Culver City, CA 90232

Gentlemen:

     In connection with the proposed spin-off of 100% of the capital stock of
HealthZone.com, a California corporation ("HealthZone"), a wholly owned
subsidiary of Irwin Naturals/4Health, Inc, a Utah corporation (the
"Company"), and in consideration of good and valuable consideration the
receipt and sufficiency of which are hereby acknowledged and confirmed the
undersigned (hereinafter referred to as the "Irwin") and the Company hereby
agree as follows:

          1.   HVE ACQUISITION AND WEB SITE. (a) Irwin hereby agrees to
               reimburse, indemnify and hold the Company harmless from any
               and all damages, liabilities, claims (including, without
               limitation, third party claims), losses, costs and expenses
               (including, without limitation, attorneys' and accountants'
               fees and disbursements) incurred by the Company in connection
               with the (i) acquisition of Health & Vitamin Express, Inc.,
               ("HVE") pursuant to the provisions of that certain Agreement
               and Plan of Merger dated February 15, 1999 by and among the
               Company, HVE, David Mandel, Jeffrey D. Segal and Gordon Barker
               ("Merger Agreement") and the performance by the Company of its
               obligations thereunder, including, without limitation, pursuant
               to the provisions of Sections 2.02, 6.02, 6.03(d), 8.05, 9.03
               and 10.11 of the Merger Agreement and (ii) development and
               implementation of the HealthZone.com web site, including,
               without limitation, all salaries, fees and expenses of
               employees and consultants engaged in the design and
               development of such web site.

               (b) Irwin hereby assumes all of the Company's obligations to
               issue additional shares of the Company's common stock
               ("Common Stock") under the Merger Agreement and the Employment
               Agreement with David Mandel from his own and his wife's,
               Margareth Irwin ("Mrs. Irwin") shares of Common Stock,
               including, without limitation, the issuance of additional
               Merger Consideration as provided pursuant to the provisions of
               Section 2.02 of the Merger Agreement.

               (c) As collateral security for his obligations under this
               Agreement, Irwin shall, and shall cause Mrs. Irwin to deposit
               in escrow one or more certificates in a form transferable by
               delivery evidencing an aggregate of 1,600,000 shares of the
               Company's Common Stock registered in joint


<PAGE>

               name with Mrs. Irwin pursuant to the terms of an escrow
               agreement to be entered into with the Company.

          2.   ADDITIONAL UNDERTAKINGS. The provisions of Section 1 shall be
               in addition to, and not in lieu of, any other obligations of
               Irwin with respect to the subject matter hereof, whether
               arising as a matter of contract, by law or otherwise,
               including, but not limited to, any obligations which may be
               contained in any employment agreement to which Irwin and the
               Company or any affiliate of the Company is a party.

          3.   EXPENSES. Except as otherwise provided in this Agreement,
               Irwin agrees to pay his own (and reimburse the Company its)
               costs and expenses, including, without limitation, all
               reasonable attorneys fees and expenses, incurred in connection
               with the negotiation, preparation, execution, delivery and
               performance of this Agreement and the transactions
               contemplated hereby.

          4.   NOTICES. All notices, requests, demands and other
               communications hereunder shall be in writing and shall be
               deemed to have been duly given or made as of the date
               delivered, if delivered personally, or one (1) Business Day
               after having been deposited with a courier, if sent by
               overnight courier or having been sent by telecopy, if sent by
               telecopy (receipt confirmed), or three (3) Business Days after
               having been mailed, if mailed by registered or certified mail,
               postage prepaid, return receipt requested, as follows:

               If to the Company, to:    Irwin Naturals/4Health, Inc.
                                   10549 W. Jefferson Boulevard
                                   Culver City, CA 90232
                                   Attn: Chairman of the Board

               Copy to:            Satterlee Stephens Burke & Burke LLP
                                   230 Park Avenue
                                   New York, NY 10169
                                   Attn: Peter A. Basilevsky, Esq.

               If to Irwin or Mrs. Irwin, to Irwin's address first above
               written, or to such other address, as any party shall have
               designated by like notice to the other parties hereto (except
               that a notice of change of address shall only be effective
               upon receipt).

          5.   APPLICABLE LAW. This Agreement shall be governed by, and
               construed in accordance with, the laws of the State of Utah
               without regard to its choice of law principles.


                                       2

<PAGE>

          6.   WAIVERS, ETC. The failure of any of the parties hereto at any
               time to enforce any of the provisions of this Agreement shall
               not be deemed or construed to be a waiver of any such
               provision, nor in any way to affect the validity of this
               Agreement or any provision hereof or the right of any of the
               parties hereto to thereafter enforce each and every provision
               of this Agreement. No waiver of any breach of any of the
               provisions Agreement shall be effective unless set forth in a
               instrument executed by the party or parties against whom
               enforcement of such waiver is sought; and no waiver of breach
               shall be construed or deemed to be a waiver of any other or
               subsequent breach.

          7.   ASSIGNMENT. Neither this Agreement nor any rights, interests
               or obligations hereunder may be assigned (by operation of law
               or otherwise) by any party hereto without the prior written
               consent of all of the parties hereto, except that the Company
               may (a) assign any and all of its rights and remedies and
               delegate any and all of its obligations under this Agreement
               to any affiliate, subsidiary or any entity owned or controlled
               by it, provided such affiliate, subsidiary or entity agrees in
               writing to be bound by the terms hereof, and (b) grant a
               security interest in its rights under this Agreement to the
               Company's lender.

          8.   BINDING EFFECT; BENEFITS. This Agreement shall inure to the
               benefit of, and shall be binding upon, the parties hereto and
               their respective successors and permitted assigns. Nothing
               herein contained, express or implied, is intended to confer
               upon any person other than the parties hereto and their
               respective successors and permitted assigns, any rights or
               remedies under or by reason of this Agreement.

          9.   AMENDMENT. This Agreement may only be amended by a written
               instrument executed by each of the parties hereto.

          10.  SEVERABILITY. Any provision of this Agreement which is held by
               a court of competent jurisdiction to be prohibited or
               unenforceable in any jurisdiction(s) shall be, as to such
               jurisdiction(s), ineffective to the extent of such prohibition
               or unenforceability without invalidating the remaining
               provisions of this Agreement or affecting the validity or
               enforceability of such provision in any other jurisdiction.

          11.  ENTIRE AGREEMENT. This Agreement (together with the escrow
               agreement to be delivered pursuant to or in connection with
               this Agreement) constitute the entire agreement of the parties
               hereto with respect to the subject matter hereof, and
               supersede all prior agreements and understandings of the
               parties, oral and written, with respect to the subject matter
               hereof.

          12.  HEADINGS. The headings contained herein are for the sole
               purpose of convenience of reference, and shall not in any way
               limit or affect the meaning or interpretation of any of the
               terms or provisions of this Agreement.


                                      3

<PAGE>


          13.  EXECUTION IN COUNTERPARTS. This Agreement may be executed in
               one or more counterparts, and by the different parties hereto
               in separate counterparts, each of which shall be deemed to be
               an original but all of which taken together shall constitute
               one and the same agreement, and shall become effective when
               one or more counterparts has been signed by each of the
               parties hereto and delivered to each of the other parties
               hereto.

          14.  FURTHER ASSURANCES. Irwin hereby agrees, at his sole cost and
               expense, to execute and deliver, and to cause Mrs. Irwin to
               execute and deliver to the Company all such further
               agreements, instruments or other documents, including, without
               limitation, an escrow agreement, as the Company may reasonably
               request in order to implement the provisions of this Agreement.

          15.  SPECIFIC PERFORMANCE. The parties hereby acknowledge and agree
               that the failure of Irwin to perform his agreements and
               covenants hereunder, will cause irreparable injury to the
               Company for which damages, even if available, will not be an
               adequate remedy. Accordingly, Irwin hereby consents to the
               issuance of injunctive relief by any court of competent
               jurisdiction to compel performance of such party's obligations
               and to the granting by any court of the remedy of specific
               performance of his obligations hereunder and in connection
               therewith Irwin hereby waives any right to require any bond or
               other security to be paid or furnished by the Company in
               connection with any application for such relief.


     If the foregoing correctly sets forth our agreement regarding the
subject matter hereof kindly indicate your approval and agreement in the
space provided therefor below on the enclosed copy of this letter returning
the same to the undersigned.


                                                      Very truly yours,


                                                      /s/ Klee Irwin


                                                      Klee Irwin


APPROVED AND AGREED
as of the date first above written

IRWIN NATURALS/4HEALTH, INC.



By:  /s/ R. Lindsey Duncan
   --------------------------------
   R. Lindsey Duncan, Chairman


                                     4




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission